Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (421-430 of 554) with videos related to

Pageof 56
Sort By:
Nature|March 8, 2023
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathyXiaoying Chen, Maria Firulyova, Melissa Manis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMaulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Science (New York, N.Y.)|March 5, 2026
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapyYun Chen, Yizhou Liu, Khai Nguyen, et al.
Annals of Neurology|January 5, 2024
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's DiseaseJeffery M Vance, Lindsay A Farrer, Yadong Huang, et al.
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Neuron|June 14, 2008
ApoE promotes the proteolytic degradation of AbetaQingguang Jiang, C Y Daniel Lee, Shweta Mandrekar, et al.
Cell Stem Cell|June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neuronsLucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Neuron|December 8, 2017
Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosisTien-Phat V Huynh, Fan Liao, Caroline M Francis, et al.
Plos One|June 8, 2012
In vivo human apolipoprotein E isoform fractional turnover rates in the CNSKristin R Wildsmith, Jacob M Basak, Bruce W Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Pageof 56

Showing results (421-430 of 554) with videos related to

Sort By:
Pageof 56
Nature|March 8, 2023
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathyXiaoying Chen, Maria Firulyova, Melissa Manis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMaulikkumar P Patel, Arda Cetin, Matthew Johnson, et al.
Science (New York, N.Y.)|March 5, 2026
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapyYun Chen, Yizhou Liu, Khai Nguyen, et al.
Annals of Neurology|January 5, 2024
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's DiseaseJeffery M Vance, Lindsay A Farrer, Yadong Huang, et al.
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Neuron|June 14, 2008
ApoE promotes the proteolytic degradation of AbetaQingguang Jiang, C Y Daniel Lee, Shweta Mandrekar, et al.
Cell Stem Cell|June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neuronsLucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Neuron|December 8, 2017
Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosisTien-Phat V Huynh, Fan Liao, Caroline M Francis, et al.
Plos One|June 8, 2012
In vivo human apolipoprotein E isoform fractional turnover rates in the CNSKristin R Wildsmith, Jacob M Basak, Bruce W Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Pageof 56